1. 2190 Discovery of new molecular subtypes of non-hypermutated metastatic colorectal cancer (mCRC) through a next-generation sequencing (NGS) approach. (September 2015) Authors: Pietrantonio, F.; Perrone, F.; Cremolini, C.; Orlandi, A.; Niger, M.; Caporale, M.; Berenato, R.; Antoniotti, C.; Loupakis, F.; Tamborini, E.; Milione, M.; Settanni, G.; Busico, A.; De Braud, F.; Di Bartolomeo, M. Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S396 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 2366 Metronomic capecitabine and bevacizumab is an active combination in patients with relapsed peritoneal pseudomyxoma. (September 2015) Authors: Maggi, C.; De Braud, F.; Di Bartolomeo, M.; Perrone, F.; Tamborini, E.; Milione, M.; Deraco, M.; Kusamura, S.; Baratti, D.; Berenato, R.; Caporale, M.; Consonni, P.V.; Niger, M.; Bossi, I.; Leo, E.; Pelosi, G.; Pietrantonio, F. Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S458 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. 2643 Neoadjuvant sorafenib, gemcitabine, and cisplatin (SGC) for muscle-invasive urothelial bladder cancer (UBC): Updated clinical and translational findings of an open-label, single group, phase 2 study. (September 2015) Authors: Necchi, A.; Giannatempo, P.; Mariani, L.; Raggi, D.; Nicolai, N.; Piva, L.; Biasoni, D.; Catanzaro, M.; Torelli, T.; Stagni, S.; Calareso, G.; Togliardi, E.; Colecchia, M.; Busico, A.; Perrone, F.; Pelosi, G.; Maffezzini, M.; Salvioni, R. Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S528 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. 3316 Non-melanoma skin cancer treated with HDR Brachytherapy and Valencia applicator in elderly patients. (September 2015) Authors: Delishaj, D.; Manfredi, B.; Laliscia, C.; Lombardo, E.; Cantarella, M.; Montrone, S.; Perrone, F.; Coraggio, G.; Cocuzza, P.; Ursino, S.; Pasqualetti, F.; Fabrini, M.G. Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S669 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. D02Feasibility and outcome of interval debulking surgery (IDS) after carboplatin-paclitaxel-bevacizumab (CPB): results from a subgroup of patient from the MITO-16A-MANGO OV2A phase 4 trial. (26th September 2015) Authors: Cecere, S.C.; Daniele, G.; Lorusso, D.; Scambia, G.; Nicoletto, M.O.; Breda, E.; Colombo, N.; Artioli, G.; Daniele, B.; Lo Re, G.; Raspagliesi, F.; Chiappa, V.; Salutari, V.; Ferrandina, G.; Greggi, S.; Baldoni, A.; Piccirillo, M.C.; Fossati, R.; Perrone, F.; Pignata, S. Journal: Annals of oncology Issue: Volume 26(2015)Supplement 6 Page Start: vi33 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. H01*A multicenter, randomised, phase 3 trial comparing fixed dose versus toxicity-adjusted dose of cisplatin + etoposide in advanced SCLC patients (pts). The STAD-1 trial. (26th September 2015) Authors: Daniele, G.; Morabito, A.; Favaretto, A.; Filipazzi, V.; Rossi, A.; Gebbia, V.; Castiglione, F.; Cavanna, L.; Maiello, E.; Valmadre, G.; Costanzo, R.; Manzo, A.; Bonanno, L.; Piazza, E.; Maione, P.; Mancuso, G.; Di Maio, M.; Piccirillo, M.C.; Gallo, C.; Perrone, F. Journal: Annals of oncology Issue: Volume 26(2015)Supplement 6 Page Start: vi Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗